|
CN104042584A
|
|
Preparation method of metoprolol tartrate sustained release tablets
|
|
CN104058977A
|
|
Synthesis, purification and content control method of fluoxertine hydrochloride capsule impurity
|
|
CN105311010A
|
|
Compound diisopropylamine dichloroacetate freeze-dried powder injection and preparation method of same
|
|
CN105310994A
|
|
Compound nicotinic acid slow-release tablet and preparation method thereof
|
|
CN105267198A
|
|
Gefarnate tablet and preparation method thereof
|
|
CN105193758A
|
|
Gliclazide sustained release tablets and preparation method thereof
|
|
CN105194647A
|
|
Medicine composition containing isinopril and amlodipine besylate and preparation method of medicine composition
|
|
CN105232481A
|
|
Meloxicam dispersible tablet and preparation method thereof
|
|
CN105311006A
|
|
Fluoxetine hydrochloride composition, preparation method and application thereof
|
|
CN105193707A
|
|
Ambroxol hydrochloride oral solution and preparation method thereof
|
|
CN105267174A
|
|
Pharmaceutical composition containing metoprolol tartrate and preparation method of pharmaceutical composition
|
|
CN105213393A
|
|
A kind of niacin sustained-release preparation and preparation method
|
|
CN104784139A
|
|
Preparation method of finasteride coating tablet
|
|
CN104784130A
|
|
Gliclazide tablet composition
|
|
CN104784107A
|
|
Preparation method of tropisetron hydrochloride oral liquid
|
|
CN104784143A
|
|
Mecobalamin tablet composition
|
|
CN104784141A
|
|
Methionine tablet composition
|
|
CN104784142A
|
|
Methionine tablet preparation method
|
|
CN104784106A
|
|
Bambuterol Hydrochloride oral liquid preparation method
|
|
CN104784132A
|
|
Clarithromycin dispersible tablet composition
|
